Real-time enrollment status for this neoadjuvant treatment clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 11:08 AM UTC
| NCT Number | NCT06959511 |
| Recruiting Status | Recruiting |
| Condition | Neoadjuvant Treatment |
| Phase | PHASE2 |
| Target Enrollment | 45 participants |
| Active Locations | 4 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | July 28, 2026 (Jul 28, 2026) |
As of August 28, 2026: Clinical trial NCT06959511 is currently recruiting participants. This phase2 study for neoadjuvant treatment is actively seeking new participants at 4 locations across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06959511 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06959511 was last updated Jul 28, 2026 (July 28, 2026). HelloStudys verifies this status automatically.